ISSN 2413-6166 (Online) · ISSN 1991-0290 (Print) · DOI prefix 10.17721/moca
УкрEn
Open access · CC BY 4.0

Fluorimetric Derivatization-Based HPLC-FL Method for the Prototype Pharmacokinetic Analysis of Selexipag in Human Plasma

Burhan Ceylan, Meltem Çayci, Cem Önal, Armağan Önal
ÖnalII
† Harran University, Faculty of Pharmacy, Department of Pharmacognosy, Sanliurfa, Turkey;
‡ Harran University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sanlıurfa, Turkey;
§ Istanbul Health and Technology University, Faculty of Pharmacy, Department of Analytical Chemistry, Istanbul, Turkey; II Istanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, 34116 Beyazit-Istanbul, Turkey *e-mail: b.ceylan022@gmail.com

Abstract

A simple and cost-effective HPLC-FL method has been developed for measuring selexipag in human plasma, showcasing its suitability for pharmacokinetic research. Selexipag was precolumn derivatized with 7-chloro-4-nitrobenzofurazan (NBD-Cl) and the fluorescent derivative was separated on a C18 (150 mm × 4.6 mm × 2.6 μm) analytical column at 30 ºC using a mobile phase composed of acetonitrile – 0.1% o-phosphoric acid in water (70:30, v/v) by isocratic elution with flow rate of 1.0 mL min-1. The method was based on measuring the derivative using fluorescence detection (λex = 380 nm, λem = 420 nm). The retention time of selexipag is 6.40 ± 0.01 min. This currently developed method was validated according to EMA criteria by evaluating the specificity, linearity, precision, accuracy, and robustness. The method was determined to be linear in a concentration range of 0.01-20 ng mL-1 with a correlation coefficient of 0.9998. LOD and LOQ were found to be 0.003 and 0.01 ng mL-1, respectively. Intraday and interday RSD values were less than 1.75%. The plasma concentration-time profile and pharmacokinetic parameters such as AUC0–t, AUC0–∞, Cmax, tmax, t1/2, were calculated according to the assays. The presented method can be effectively used for bioequivalence and bioavailability investigations, as well as for routine analysis of the drug in plasma.

Keywords:selexipagHPLC-FLpre-column derivatizationpharmacokineticsNBD-Cl

How to cite

Burhan Ceylan, Meltem Çayci, Cem Önal, Armağan Önal. Fluorimetric Derivatization-Based HPLC-FL Method for the Prototype Pharmacokinetic Analysis of Selexipag in Human Plasma. Methods Objects Chem. Anal. 2025, 20(2), 117-122. https://doi.org/10.17721/moca.2025.117-122